Open Beta
TREN
MetriLume
TREN

US marketsRCKT

SEC-sourced researchBeta

RCKT

ROCKET PHARMACEUTICALS, INC.

Company comparison ↗

Data passport

CIK
0001281895
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 0.0000 USD; December 2025: 0.0000 USD0 USD0 USD0December 2024December 2025
RCKT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20240.0000Feb 26, 2026
December 20250.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20250.0000-223,123,000.0000-190,014,000.0000330,449,000.000053,228,000.0000Feb 26, 2026
December 20240.0000-258,746,000.0000-209,724,000.0000527,700,000.000064,466,000.0000Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$0December 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$0December 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$223.12MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$190.01MDecember 2025Feb 26, 202610-K
Total assetsAssets$330.45MDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$53.23MDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗